Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. (Q47207776)
Jump to navigation
Jump to search
scientific article published in November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. |
scientific article published in November 2008 |
Statements
Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial (English)
Micol Del Giglio
Vincenzo Di Francesco
Mauro Zamboni
Giampiero Girolomoni
1 November 2008